What's the difference between NAD+ and NMN or NR?

NAD+ is the actual coenzyme your cells use for energy and DNA repair. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors — building blocks the body converts into NAD+ — and they are taken orally. Human trials show oral NR and NMN reliably raise blood NAD+ levels; injectable products usually deliver NAD+ itself. NAD+ is a coenzyme and small molecule, not a peptide.

Why does the IV have to be given so slowly?

Because fast infusion causes intense flushing, chest or throat tightness, nausea and abdominal cramping — likely partly a niacin-flush-type reaction. These effects are rate-dependent, so clinics run the drip slowly (often two to four hours) and slow or pause it if symptoms appear; they typically settle quickly once the rate drops.

What's NAD+'s half-life and a typical dose?

The human half-life of infused NAD+ is poorly characterized — it is metabolized rapidly and there is scientific debate over how much intact NAD+ even enters cells. Commonly reported doses, not a recommendation, are roughly 250 to 1000 mg per IV session and about 50 to 100 mg subcutaneously. These come from clinic practice and small pilots, not from established dosing guidelines.

NAD+: the coenzyme, explained

Q: Is IV NAD+ approved or proven to slow aging?

No. Injectable and IV NAD+ are not FDA-approved drugs for anti-aging, energy or wellness, and a 2026 systematic review found no quality human trials showing injected NAD+ reverses aging or reliably boosts energy. The longevity case rests largely on animal and lab data plus precursor studies. It is sold through wellness clinics, not as a proven medicine.

Q: Is NAD+ banned in sport?

No — NAD+ and its precursors (NMN, NR, niacin) are not on the WADA Prohibited List; they are coenzyme and vitamin-adjacent. But athletes should note a separate rule: WADA prohibits intravenous infusions over 100 mL per 12 hours as a method (outside hospital care or a granted exemption), so a large-volume NAD+ drip could breach anti-doping rules even though the substance itself is allowed.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy and DNA repair — and a fixture of "longevity" IV drips and injections. First, a correction most pages skip: NAD+ is not a peptide, it's a coenzyme, sold alongside peptides but a different thing entirely. The honest headline: the biology is real, the injectable anti-aging evidence is thin. This page covers what it does, what the human data actually shows, NAD+ vs its precursors NMN and NR, why the IV has to run slowly, the dosing math, the anti-doping nuance, and how to track it. It is not dosing or sourcing advice.

By OptiPin Editorial·Last verified June 2026

Status — as of June 2026

A natural coenzyme. Not an approved anti-aging drug. NAD+ is a molecule your body already makes; injectable and IV NAD+ are sold by wellness/longevity clinics but are not FDA-approved for anti-aging, energy or any wellness indication, and the human evidence for those uses is weak. NAD+ and its precursors (NMN, NR, niacin) are not on the WADA list — but note WADA separately prohibits IV infusions over 100 mL per 12 hours as a method, so a large-volume drip can still breach anti-doping rules. Nothing here is a recommendation to infuse or inject it.

Class

Coenzyme (not a peptide)

Marketed for

Energy / longevity

Route

IV / subcutaneous

Status

Not approved · not WADA-listed

TL;DR

• NAD+ is a coenzyme (energy metabolism, sirtuins, DNA repair) that declines with age — not a peptide.
• Biology is real; injectable anti-aging evidence is thin. "IV NAD+ reverses aging" is not established in humans.
• NMN & NR are oral precursors that reliably raise blood NAD+ in trials — better human data than injected NAD+, but raising the number ≠ proven benefit.
• Fast IV causes flushing/nausea/chest tightness, so it's run slowly. Not WADA-banned (but the >100 mL/12 h IV method is).

What NAD+ is

NAD+ is a coenzyme present in every cell, central to energy metabolism — it carries electrons in the redox reactions (NAD+ ⇌ NADH) that drive ATP production. Beyond energy, it's a consumed substrate for three enzyme families: sirtuins (metabolic/stress signaling), PARPs (DNA repair), and CD38 (which rises with age and inflammation). NAD+ levels decline with age, which is the usual rationale offered for "topping it up." It is a coenzyme and small molecule — not a peptide; it's grouped with peptides here only because it's sold in the same longevity/clinic context.

NAD+ vs its precursors (NMN, NR)

A distinction worth getting right. NAD+ is the end coenzyme; most oral products are precursors the body converts into NAD+ — chiefly NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), plus niacin and nicotinamide. Injectable/IV products usually deliver NAD+ itself. Crucially, the human evidence is much stronger for precursors raising NAD+ than for injected NAD+ doing anything clinical: randomized trials show oral NR and NMN reliably raise blood NAD+ levels and are well tolerated — but that's a biomarker, not a proven outcome.

What the evidence actually shows

The honest version. The biology of NAD+ is well established — it's a real, essential coenzyme. But the marketed benefits of injectable/IV NAD+ (anti-aging, energy/fatigue, mood, addiction recovery, hangover, athletic performance) are not proven in quality human trials. A 2026 systematic review found no eligible outcomes trials for IV/injectable NAD+ in anti-aging or wellness, and the longevity case rests largely on animal and in-vitro data plus precursor studies. "IV NAD+ reverses aging" is a hypothesis, not an established fact — and there's even open scientific debate about how much intact infused NAD+ actually enters cells versus being broken down to precursors first. Treat it as an unproven wellness intervention with real biology behind the molecule but weak clinical evidence behind the needle.

Why the IV runs slowly — and the math

The single most practical fact about IV NAD+: given fast, it causes intense flushing, chest or throat tightness, nausea and abdominal cramping. These effects are rate-dependent — likely partly a niacin-flush-type reaction — so clinics deliberately run the drip slowly, often over two to four hours, slowing or pausing it when symptoms appear; they usually settle quickly once the rate drops. In one tolerability pilot, a 500 mg IV NAD+ infusion averaged ~97 minutes precisely because participants needed the rate slowed.

For a subcutaneous dose, the arithmetic is the same reconstitution math the peptide reconstitution calculator does — NAD+ is dosed in milligrams. Worked example, purely as arithmetic:

Vial label	500 mg NAD+ (powder or pre-mixed)
Reconstitute to	5 mL → 100 mg/mL
Per 0.1 mL	10 mg — i.e. 10 units on a U-100 syringe = 10 mg
So a 50 mg SC dose would be	0.5 mL = 50 units

For IV use the dose is typically diluted into saline (e.g. 500 mg in 500 mL) and infused slowly. The reported half-life of infused NAD+ is poorly characterized in humans — so this page deliberately doesn't quote a number. The milligrams above are illustrative arithmetic, not a recommended dose — commonly reported figures are ~250–1000 mg per IV session or ~50–100 mg SC, but no validated dosing guideline exists.

Storage & handling

Powder (unreconstituted): kept cold and away from light; NAD+ is sensitive to heat and moisture.
Reconstituted / pre-mixed: refrigerated; used within the window the product specifies. Discard if discoloured.
SC injection can sting, and IV must be run slowly (see above).
Quality honesty: clinic-compounded and research-grade injectable NAD+ is outside the FDA-approved-drug framework — purity, content and sterility are not guaranteed.

This is not a prescription, a dose, or a sourcing guide. Injectable/IV NAD+ is an unproven wellness intervention, not an approved medicine, with rate-dependent infusion reactions and limited long-term safety data. We are not prescribers. Discuss any infusion or injectable with a qualified clinician — and note the WADA large-volume-IV rule if you compete.

Tracking NAD+ in OptiPin

If you are tracking an NAD+ protocol (or an oral precursor), OptiPin treats it like any other entry — without endorsing the injectable use:

Dose / session log + reminders — record each IV session or SC dose (or oral NMN/NR) and get reminded on schedule.
Energy & symptom tracking — log the outcome you actually care about (energy, sleep, mood) over time so a trend lines up against sessions — the honest way to judge an unproven intervention on yourself.
OptiInsight analysis — OptiPin's AI reads the full record (doses, symptoms, labs) and surfaces what moved with what.
Supply tracking — log the vial; OptiPin estimates remaining doses and an empty date.
Built-in reconstitution math — the same calculator covered above is in the app for the mg-to-syringe-unit conversion.

Track it properly

Log sessions, energy & supply in OptiPin

Reminders, energy/symptom-over-session charts, supply countdown, built-in reconstitution math, and OptiInsight analysis — all on-device. The honest way to see whether an unproven intervention is doing anything for you.

Download on the App Store

FAQ

Is IV NAD+ approved or proven to slow aging?

No — not FDA-approved for anti-aging/energy/wellness, and a 2026 systematic review found no quality human trials showing injected NAD+ reverses aging. The longevity case rests on animal/lab data and precursor studies. Sold via wellness clinics, not as a proven medicine.

NAD+ vs NMN/NR?

NAD+ is the coenzyme itself. NMN and NR are oral precursors the body converts to NAD+; trials show they reliably raise blood NAD+. Injectables usually deliver NAD+ directly. NAD+ is a coenzyme, not a peptide.

Why does the IV have to go slowly?

Fast infusion causes flushing, chest/throat tightness, nausea and cramping (a niacin-flush-type reaction). These are rate-dependent, so clinics run it over 2–4 hours and slow/pause if symptoms appear; they settle quickly once the rate drops.

Half-life and dosing?

Human half-life of infused NAD+ is poorly characterized (and how much intact NAD+ enters cells is debated). Commonly reported: ~250–1000 mg per IV session, ~50–100 mg SC. Clinic practice, not a guideline. Not a recommendation.

Is NAD+ banned in sport?

No — NAD+ and precursors (NMN, NR, niacin) aren't on the WADA list. But WADA prohibits IV infusions over 100 mL per 12 hours as a method (outside hospital care/exemption), so a large-volume drip could still breach the rules even though the substance is allowed.

Educational only, not medical advice. Injectable/IV NAD+ is an unproven wellness intervention, not an approved medicine, with rate-dependent infusion reactions and limited long-term safety data. OptiPin does not recommend obtaining or using it. Discuss any infusion with a qualified clinician.

Sources

BPC-157 · GHK-Cu · Peptides guide · Peptide reconstitution calculator · Bloodwork · Injection technique